Whitehawk Therapeutics (WHWK) Total Non-Current Liabilities (2020 - 2025)

Whitehawk Therapeutics (WHWK) has 6 years of Total Non-Current Liabilities data on file, last reported at $14.5 million in Q4 2025.

• Total Non-Current Liabilities for Q4 2025 came in at $14.5 million, down 17.69% year-over-year; the trailing twelve-month figure through Dec 2025 was $14.5 million (down 17.69% YoY), and the FY2025 annual result was $14.5 million, down 17.69% from the prior year.
• Total Non-Current Liabilities grew to $14.5 million in Q4 2025 per WHWK's latest filing, from $9.8 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $27.2 million in Q4 2023 and troughed at $8.8 million in Q2 2025.
• A 5-year average of $16.4 million and a median of $16.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
• On a YoY basis, Total Non-Current Liabilities climbed as much as 17.69% in 2025 and fell as far as 40.08% in 2025.
• A 5-year view of Total Non-Current Liabilities shows it stood at $21.5 million in 2021, then dropped by 7.94% to $19.8 million in 2022, then jumped by 37.54% to $27.2 million in 2023, then plunged by 35.22% to $17.6 million in 2024, then retreated by 17.69% to $14.5 million in 2025.
• Business Quant data shows WHWK's Total Non-Current Liabilities at $14.5 million in Q4 2025, $9.8 million in Q3 2025, and $8.8 million in Q2 2025.